Similar research also reported that SPINK1 expression in HCC cells was associated with HCC via activating the c-Raf/MEK/ERK pathway, which suggested that inhibiting the MEK pathway and usage of selumetinib could be a potential treatment strategy for HCC(37). The gene discussed is SPINK1; the disease is hepatocellular carcinoma.